Literature DB >> 24532908

Steroid resistant nephrotic syndrome in a child with chronic hepatitis B infection.

Sandeep Dhingra1, Madhuri Kanitkar2, Prasanta Sengupta3.   

Abstract

Steroid resistant nephrotic syndrome (SRNS) continues to be a challenge for pediatric nephrologists the world over. Secondary causes of nephrotic syndrome need to be searched for in all cases of steroid resistance. Hepatitis B virus (HBV) is associated with several types of glomerulonephritis, most commonly being membranous nephropathy (MN) in children. It is an important cause of secondary nephrotic syndrome in countries with high prevalence of chronic hepatitis B virus (HBV) infection. We present a case of SRNS in a 5-yr-old boy who had received 3 weeks of daily steroids before referral to our hospital. At presentation the child had urinary tract infection (UTI) which was adequately treated. The child had persistence of proteinuria, even after completing 4 weeks of daily steroids in adequate dose. Secondary causes of nephrotic syndrome were looked for which revealed presence of chronic HBV infection in the patient with a very high viral load. Kidney biopsy was characteristic of MN with predominant IgG, & minor IgM, and C3 deposits in subepithelial region. The child responded to treatment with Lamivudine with reduction in edema and proteinuria.

Entities:  

Keywords:  Lamivudine; Membranous nephropathy; Secondary nephrotic syndrome

Year:  2012        PMID: 24532908      PMCID: PMC3862750          DOI: 10.1016/j.mjafi.2011.12.003

Source DB:  PubMed          Journal:  Med J Armed Forces India        ISSN: 0377-1237


  9 in total

1.  Lamivudine and interferon-alpha combination treatment of childhood patients with chronic hepatitis B infection.

Authors:  B Dikici; M Bosnak; I H Kara; O Dogru; A Dagli; F Gürkan; K Haspolat
Journal:  Pediatr Infect Dis J       Date:  2001-10       Impact factor: 2.129

2.  Clinical trial of lamivudine in children with chronic hepatitis B.

Authors:  Maureen M Jonas; Deirdre A Kelley; Jacek Mizerski; Isabel B Badia; Jorge A Areias; Kathleen B Schwarz; Nancy R Little; Martin J Greensmith; Stephen D Gardner; M Steve Bell; Etienne M Sokal
Journal:  N Engl J Med       Date:  2002-05-30       Impact factor: 91.245

3.  High prevalence of hepatitis B surface antigenaemia in nephrotic syndrome in Hong Kong.

Authors:  K N Lai; F M Lai; J S Tam; C B Chow; T C Au
Journal:  Ann Trop Paediatr       Date:  1989-03

4.  Improvement of hepatitis B-associated glomerulonephritis after antiviral combination therapy.

Authors:  R A de Man; S W Schalm; A J van der Heijden; F W ten Kate; E D Wolff; R A Heijtink
Journal:  J Hepatol       Date:  1989-05       Impact factor: 25.083

5.  Sequential treatment with lamivudine and interferon monotherapies in patients with chronic hepatitis B not responding to interferon alone: results of a pilot study.

Authors:  L Serfaty; D Thabut; F Zoulim; T Andreani; O Chazouillères; N Carbonell; A Loria; R Poupon
Journal:  Hepatology       Date:  2001-09       Impact factor: 17.425

6.  Hepatitis B-associated nephrotic syndrome in Jamaican children.

Authors:  M E Y Miller; R B Pierre; M H Plummer; D J Shah
Journal:  Ann Trop Paediatr       Date:  2002-09

Review 7.  Interferon-alpha-2a. A review of its pharmacological properties and therapeutic use in the management of viral hepatitis.

Authors:  M Haria; P Benfield
Journal:  Drugs       Date:  1995-11       Impact factor: 9.546

Review 8.  Hepatitis B virus-associated nephropathy.

Authors:  Rajendra Bhimma; Hoosen Mohamed Coovadia
Journal:  Am J Nephrol       Date:  2004-02-25       Impact factor: 3.754

Review 9.  Hepatitis B virus associated focal and segmental glomerular sclerosis: report of two cases and review of literature.

Authors:  Ambar Khaira; Bala Krishna Upadhyay; Alok Sharma; Prasenjit Das; Sandeep Mahajan; Govind Makhariya; Amit K Dinda; Sanjay K Agarwal; Suresh C Tiwari
Journal:  Clin Exp Nephrol       Date:  2009-01-24       Impact factor: 2.617

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.